CABA | Cabaletta BioNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$1.42
-$0.01 (-0.70%)

Cabaletta Bio (CABA) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2020.

The 50 SMA has sat below the 200 on the daily since Sep 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $1.42 vs 50 $2.24 / 200 $2.85
Projection
No cross projected
Test
No active test
Last cross
Death cross 15 Sep 2026 ยท projected 6 bars out ยท tested 1 bar

Weekly as of 30 Oct 16:00 ET

Price
below both $1.51 vs 50 $2.75 / 200 $7.20
Projection
No cross projected
Test
No active test
Last cross
Death cross week of 20 Jan 2025 ยท projected 27 bars out

4-hour as of 3 Nov 13:30 ET

Price
below both $1.44 vs 50 $1.67 / 200 $2.57
Projection
No cross projected
Test
No active test
Last cross
Death cross 6 Jul 2026 bar 1 ยท projected 30 bars out ยท tested 6 bars

Cross history

19
crosses on record since 2020
9 golden10 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
15 Sep 2026Death flatdaily6 bars out1 bar cross test
6 Jul 2026Death4-hour30 bars out6 bar cross test
9 Feb 2026Golden4-hour14 bars out4 bar cross test
14 Jan 2026Death4-hour15 bars out4 bar cross test
9 Oct 2025Golden moderatedaily16 bars outNot tested

About CABA

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$10.7M
4-hour coverageYes, since Oct 2025
History on recordSince 2020
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.